Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Gastroesophageal heterotopia and HER2/neu overexpression in an adenocarcinoma arising from a small bowel duplication.

Nussbaum DP, Bhattacharya SD, Jiang X, Cardona DM, Strickler JH, Blazer DG 3rd.

Arch Pathol Lab Med. 2014 Mar;138(3):428-31. doi: 10.5858/arpa.2012-0523-CR.

PMID:
24576036
2.

HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas.

Gu MJ, Hong SM, Jung SJ; Korean Small Intestinal Cancer Study Group.

Virchows Arch. 2013 Jun;462(6):603-7. doi: 10.1007/s00428-013-1425-1. Epub 2013 May 24.

PMID:
23703294
3.

Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma.

Chan OT, Chen ZM, Chung F, Kawachi K, Phan DC, Himmelfarb E, Lin F, Perry A, Wang HL.

Am J Clin Pathol. 2010 Dec;134(6):880-5. doi: 10.1309/AJCPK6QHNNOEMJIM.

PMID:
21088150
4.
5.

High chromosomal instability in adenocarcinoma of the ileum arising from multifocal gastric heterotopia with gastritis cystica profunda.

Schaefer IM, Schüler P, Enders C, Scharf JG, Cameron S, Ramadori G, Füzesi L.

Med Oncol. 2011 Dec;28(4):1023-6. doi: 10.1007/s12032-010-9604-2. Epub 2010 Jun 25.

6.
7.

Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma.

Madani SH, Rahmati A, Sadeghi E, Khazaei S, Sadeghi M, Payandeh M, Amirifard N.

Asian Pac J Cancer Prev. 2015;16(17):7755-8.

8.

Gastrin-producing cells in ectopic gastric mucosa of developmental and metaplastic origins.

Dayal Y, Wolfe HJ.

Gastroenterology. 1978 Oct;75(4):655-60.

PMID:
361486
9.

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

Thompson SK, Sullivan TR, Davies R, Ruszkiewicz AR.

Ann Surg Oncol. 2011 Jul;18(7):2010-7. doi: 10.1245/s10434-011-1554-1. Epub 2011 Jan 26.

PMID:
21267790
10.
11.

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

Latif Z, Watters AD, Dunn I, Grigor K, Underwood MA, Bartlett JM.

Eur J Cancer. 2004 Jan;40(1):56-63.

PMID:
14687790
12.

Early HER2 dysregulation in gastric and oesophageal carcinogenesis.

Fassan M, Mastracci L, Grillo F, Zagonel V, Bruno S, Battaglia G, Pitto F, Nitti D, Celiento T, Zaninotto G, Fiocca R, Rugge M.

Histopathology. 2012 Nov;61(5):769-76. doi: 10.1111/j.1365-2559.2012.04272.x. Epub 2012 Aug 9.

PMID:
22882541
13.

Adenocarcinoma arising in a cystic duplication of the small bowel: case report and review of literature.

Blank G, Königsrainer A, Sipos B, Ladurner R.

World J Surg Oncol. 2012 Apr 10;10:55. doi: 10.1186/1477-7819-10-55. Review.

14.

Heterotopic gastric mucosa of the small bowel with perforated ulcer.

Briggs FL, Moore JP.

Am Surg. 1979 Jun;45(6):413-7.

PMID:
453736
16.
17.

Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.

Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P.

Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):1031-6.

PMID:
17938328
18.

Adenocarcinoma of the small bowel arising from a previous strictureplasty for Crohn's disease: report of a case.

Menon AM, Mirza AH, Moolla S, Morton DG.

Dis Colon Rectum. 2007 Feb;50(2):257-9.

PMID:
17180254
19.

Squamous cell carcinoma arising in a duplication of the small bowel.

Adair HM, Trowell JE.

J Pathol. 1981 Jan;133(1):25-31.

PMID:
7205440
20.

Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.

Kazakov DV, Ivan D, Kutzner H, Spagnolo DV, Grossmann P, Vanecek T, Sima R, Kacerovska D, Shelekhova KV, Denisjuk N, Hillen U, Kuroda N, Mukensnabl P, Danis D, Michal M.

Am J Dermatopathol. 2009 May;31(3):236-47. doi: 10.1097/DAD.0b013e3181984f10.

PMID:
19384064

Supplemental Content

Support Center